Navigation Links
CI Faculty Member Awarded Nearly $1 Million NSF Grant
Date:9/9/2009

CAMARILLO, Calif., Sept. 9 /PRNewswire-USNewswire/ -- California State University Channel Islands announced that the National Science Foundation (NSF) recently honored Dr. Blake Gillespie, Assistant Professor of Chemistry, with the prestigious NSF Faculty Early Career Development (CAREER) award.

The award, a five-year, $920,552 grant in recognition of Gillespie's teaching and research in protein-ligand interactions and biomolecular dynamics, is supported by funding from the American Recovery and Reinvestment Act of 2009.

Gillespie's project, 'Binding and Biomolecular Dynamics in Undergraduate Teaching and Research,' examines how proteins are affected by other molecules they encounter in the cell. Gillespie explained that he was focused on the forces that make biological molecules function or malfunction, that make proteins fold and unfold. "Diseases like Alzheimer's and Mad Cow are examples of proteins not folding properly. An understanding of this process will allow us to re-engineer biological molecules to do a better or different job," maintains Gillespie.

Gillespie's lab deals with the fundamentals of molecular biophysics. Many of his experiments and research will be woven directly into the curriculum of several CI science courses. Dr. Gillespie's award will provide the University's students in regular classes with experiential learning opportunities and with actual research laboratory experiences that support the work of faculty researchers. The grant also provides summer research internships for designated groups of high school students and their science teachers.

"Support for stellar scientists like Dr. Gillespie is a wise investment at a time when funding to higher education is in jeopardy. I know that there will be substantial returns in terms of strengthening the educational pipeline for careers in the sciences and the potential to improve understanding and treatment of diseases," stated President Richard R. Rush.

Dr. Gillespie stated, "This grant provides for students at so many levels: my own research assistants, every CI chemistry major, many biology majors, and high school students in our community. In the end, the project is really dedicated to providing opportunities for all of them."

For media inquiries contact Nancy Gill, Director of Communication & Marketing at CSU Channel Islands at 805-437-8456 or nancy.gill@csuci.edu.

CSU Channel Islands is accredited by the Accrediting Commission for Senior Colleges and Universities of the Western Association of Schools and Colleges.

CSUCI Mission Statement

Placing students at the center of the educational experience, California State University Channel Islands provides undergraduate and graduate education that facilitates learning within and across disciplines through integrative approaches, emphasizes experiential and service learning, and graduates students with multicultural and international perspectives.


'/>"/>
SOURCE California State University Channel Islands
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
2. Eight Graduate Nursing Students Selected to Receive The California Endowment-AACN Minority Nurse Faculty Scholarship
3. Rutgers College of Nursing faculty member Rachel Jones wins New York Times Nurse Award
4. UNC faculty and students to develop plan to get clean water in poorer homes
5. UNT Health Science Center Appoints Eight New Faculty Members
6. Rutgers College of Nursing faculty member Rachel Jones awarded Rutgers-Newark Provost Award
7. Einstein honors Dr. Stanley Nathenson with Marshall S. Horwitz Faculty Prize for Research Excellence
8. AACN Concerned That the Presidents FY 2009 Budget Request Will Prolong the Nursing and Nurse Faculty Shortage
9. First Group of Minority Nurse Faculty Scholars Selected by the Johnson & Johnson Campaign for Nursings Future and AACN
10. APIC selected as faculty in Blue Shield of California Foundation initiative to fight HAIs
11. APIC Selected as Faculty in Blue Shield of California Foundation Initiative to Fight Healthcare-Associated Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly introduces the ... instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ... hour rated lamps utilize the existing electronic ballast, saving labor and maintenance costs. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back ... joined the revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified ... The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood ... to the labor and delivery team at Women’s Hospital at Renaissance in Edinburg for ... birth at the hospital and decide to donate. , “Women’s Hospital at Renaissance ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early ... substantially improve drug safety and minimize the cost of development. In this webinar, ... inhibition using cell lines and for cardiac toxicity using induced pluripotent stem cells ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Bill Howe ... industry in the coastal communities. After Tina Howe joined the team, the Bill Howe ... employees, honest services at affordable rates, and giving back to the San Diego community ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, the ... unveiled a new store design to enhance the ... healthier food, health-focused products and expanded beauty selections ... help customers discover new offerings. Together with its ... evolution of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: